PHAT · Phathom Pharmaceuticals, Inc. · Executive Compensation
Market Cap
$676.33M
Shares
80.90M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steven L. Basta | CEO | $6,968,070 |
| Steven Basta | President and Chief Executive Officer | $6,968,070 |
| Terrie Curran | Former President and Chief Executive Officer | $4,936,791 |
| Sanjeev Narula | Chief Financial and Business Officer | $3,617,962 |
| Azmi Nabulsi | M.D., M.P.H. Former Chief Operating Officer | $2,714,314 |
| Anne Marie Cook | Chief Legal Officer and Secretary | $2,100,002 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | Former President and Chief Executive Officer | $3,564,883 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $1,566,541 |
| Molly Henderson | Chief Financial and Business Officer | $1,424,212 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | Former President and Chief Executive Officer | $3,411,022 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $2,035,913 |
| Molly Henderson | Chief Financial and Business Officer | $1,873,793 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | President and Chief Executive Officer | $5,039,878 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $2,762,453 |
| Molly Henderson | Chief Financial and Business Officer | $2,648,537 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | President and Chief Executive Officer | $6,272,655 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $4,321,236 |
| Anthony Guzzo | Chief Accounting Officer | $1,365,153 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | President and Chief Executive Officer | $4,634,454 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $2,364,214 |
| Todd P. Branning | Chief Financial Officer | $2,047,404 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Terrie Curran | President and Chief Executive Officer — | $3,459,096 |
| David Socks | Chief Financial Officer | $542,127 |
| Azmi Nabulsi | M.D., M.P.H. Chief Operating Officer | $531,029 |
| Aditya Kohli | Chief Business Officer | $280,820 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sanjeev Narula | principal financial officer | Appointed | 2025-10-06 |
| Sanjeev Narula | Chief Financial and Business Officer | Appointed | 2025-10-06 |
| Theodore R. Schroeder | Class I director | Appointed | 2025-04-16 |
| Terrie Curran | member of the Company's Board of Directors | Resigned | 2025-04-01 |
| Terrie Curran | Chief Executive Officer | Resigned | 2025-04-01 |
| Terrie Curran | President | Resigned | 2025-04-01 |
| Steven Basta | Class I director | Appointed | 2025-04-01 |
| Steven Basta | President | Appointed | 2025-04-01 |
| Steven Basta | Chief Executive Officer | Appointed | 2025-04-01 |
Key facts
CIK
1783183
CUSIP
71722W107
13F (30d)
64 filings
64 filers
Visit website
Investor relations